A randomized, double-blind, placebo-controlled, dose-ranging Phase 2 study of brivekimig followed by a maintenance period in participants with moderate to severe hidradenitis suppurativa

Project: Research

Project Details

StatusActive
Effective start/end date18/11/25 → 17/11/27

Keywords

  • clinical trial
  • acne
  • hidradenitis suppurativa

Clinical Trial Phase

  • Phase II
  • External Sponsor